Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Adrabetadex by Mandos for Coronary Artery Disease (CAD) (Ischemic Heart Disease): Likelihood of Approval
Adrabetadex is under clinical development by Mandos and currently in Phase II for Coronary Artery Disease (CAD) (Ischemic Heart Disease)....
Data Insights
Adrabetadex by Beren Therapeutics PBC for Atherosclerosis: Likelihood of Approval
Adrabetadex is under clinical development by Beren Therapeutics PBC and currently in Phase I for Atherosclerosis. According to GlobalData, Phase...